Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Lange, M. Jakobsen, N. Anker, J. Dollerup, P.B. Poulsen (Copenhagen, Lyngby, Ballerup, Denmark). The drug costs associated with COPD prescription medicine in Denmark. Eur Respir J 2012; 40: Suppl. 56, 1293

Member's Comments

No comment yet.

Related content which might interest you: Antibiotics prescriptions increased medical costs for COPD exacerbations. Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 Active tobacco smoking and costs of COPD exacerbations in secondary medical care in Poland Source: Eur Respir J 2007; 30: Suppl. 51, 194s Year: 2007 Prescription of inhaled corticosteroids for COPD in general practice in Denmark – changes after participating in an educational programme Source: Annual Congress 2008 - Management of COPD Year: 2008 Prescription rates for various classes of COPD & asthma medication in Turkey Source: Eur Respir J 2001; 18: Suppl. 33, 425s Year: 2001 Impact of once-daily single inhaler triple therapy on healthcare resource utilization and associated costs in COPD patients in Spain Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018 Manner of treatment and costs of COPD exacerbations in secondary medical care in Poland Source: Eur Respir J 2007; 30: Suppl. 51, 194s Year: 2007 Oral corticosteroid prescription patterns in asthma care in Italy Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Using pharmacy sales data to estimate treated COPD prevalence in Portugal Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Inappropriate overuse of inhaled corticosteroids in patients with moderate COPD in UK primary care Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011 COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Unlicensed and off-label prescription of respiratory drugs to children Source: Eur Respir J 2004; 23: 310-313 Year: 2004 Pharmaceutical cost of treatment in Greek COPD outpatients Source: Annual Congress 2009 - Sustainability in treatment of COPD patients according to economics and quality of care Year: 2009 Real-world medication use patterns in stable COPD patients from Romania Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Antibiotic prescribing practises of hospital doctors for COPD exacerbations Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Asthma-related resource use and costs for patients prescribed inhaled corticosteroids compared to leukotriene modifiers in clinical practice Source: Annual Congress 2010 - Management of airway disease Year: 2010 The prevalence of symptoms suggestive of COPD amongst patients attending an illicit drug misuse clinic Source: Annual Congress 2013 –COPD and tobacco management Year: 2013 Suboptimal asthma control among over-the-counter reliever purchasers in the community pharmacy. Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019 De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Prescribing patterns of inhaled corticosteroids in asthma amongst primary care physicians in Singapore Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021 The differences of medication use between women with persistent asthma receiving care from specialty and non-specialty clinics Source: Eur Respir J 2005; 26: Suppl. 49, 277s Year: 2005